Clinical research company Science 37 nets $29 mln Series C
Los Angeles-based Science 37, a clinical research company, has secured $29 million in Series C funding. Glynn Capital Management led the round with participation from GV, Amgen Ventures, Lux Capital, Redmile Group, dRx Capital and Sanofi Ventures.
25 April 2017•1 min read
